reference/5195864

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5195864

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	4810
issn	1527-7755 0732-183X
issueIdentifier	36
pageRange	4803-4810
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	4803
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b1f62c5cffb37c7d1cc74bd62fc95e06 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_45df3ef785bb27d21da0f886965a8a1c
bibliographicCitation	Lennerz JK, Kwak EL, Ackerman A, Michael M, Fox SB, Bergethon K, Lauwers GY, Christensen JG, Wilner KD, Haber DA, Salgia R, Bang YJ, Clark JW, Solomon BJ, Iafrate AJ. MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. J Clin Oncol. 2011 Dec 20;29(36):4803–10. PMID: 22042947; PMCID: PMC3255989.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f160769bfe6fa0771c1f143572a2047c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1ae77f61a1dbb2c8ca12c4d3280ecf4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45efdb864e1eb4e86e43b9f9c10cfe7e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd6d164b52eb10c7fb5e62fca4a24ccb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0fb202ba6c0e1e203d5b9f08eacecb3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f2a8b6ae5b3afdf28164386aab02dac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dce68b61044e581129b4e52f14a01e6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77f7df78062256920d3ff254454796ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59df44238ad73f1b247e4626ec9fd93a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91246700063e17a85fdbc6fcca5ba910 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef6dbe0e0601c591a99adb6fb3d4936b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7a06f64138ebd5503d98cb19408effe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1915f73e05fa3df698dab4c3ad332961 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_854777c2dfe7438223d5405c4ebab1d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7ce656875f5cc63c0270d2835c42fb1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7648-8896
date	2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2011.35.4928 https://pubmed.ncbi.nlm.nih.gov/22042947 https://pubmed.ncbi.nlm.nih.gov/PMC3255989
isPartOf	https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
discusses	http://id.nlm.nih.gov/mesh/M0029482 http://id.nlm.nih.gov/mesh/M0491589 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0553416 http://id.nlm.nih.gov/mesh/M000745465 http://id.nlm.nih.gov/mesh/M0468309
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D004938Q000235 http://id.nlm.nih.gov/mesh/D019859Q000235 http://id.nlm.nih.gov/mesh/D019859Q000037 http://id.nlm.nih.gov/mesh/D013274Q000235 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D000230Q000235 http://id.nlm.nih.gov/mesh/D011720Q000627 http://id.nlm.nih.gov/mesh/D005784 http://id.nlm.nih.gov/mesh/D011725Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D066246Q000235 http://id.nlm.nih.gov/mesh/D004938Q000473 http://id.nlm.nih.gov/mesh/D000090063 http://id.nlm.nih.gov/mesh/D018734 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000230Q000473 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D013274Q000473 http://id.nlm.nih.gov/mesh/D004938Q000188 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D013274Q000188 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000077547 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015331
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7172 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7464 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c4c4909eaa4fc41a39f0fa5c96f30cd6 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229599 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID160644611 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243164928

Total number of triples: 87.